Evaluating Therapeutic Response to Novo-TTF
NCT02441322
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
DEVICE:
Novo-TTF
Sponsor
Abramson Cancer Center at Penn Medicine